Total neoadjuvant therapy (TNT) for rectal cancer

For decades, the standard approach for locally advanced rectal cancer was to give a course of radiotherapy (with or without chemotherapy) before surgery, then more chemotherapy after surgery once you had recovered. This worked — but it had a familiar problem: many patients found post-operative chemotherapy hard to complete, because they were still recovering from major bowel surgery. Tiredness, complications, stoma adjustment, and reduced appetite all chip away at how much chemotherapy can actually be delivered.

Total neoadjuvant therapy turns this sequence around. Neoadjuvant simply means "before surgery". Total means all of it — both the chemotherapy and the radiotherapy — is given up front, while you are at your strongest. Surgery, if it is still needed, happens afterwards.

There are four reasons your team may recommend a TNT pathway:

• Better completion of treatment. Patients are at their fittest before surgery. Studies have shown that more people complete the full planned course of chemotherapy when it is given before surgery, rather than after.
• Earlier treatment of microscopic spread. Even when scans look clear, a small number of cancer cells may have already travelled elsewhere in the body. Giving chemotherapy earlier — rather than waiting until weeks after surgery — treats this potential spread sooner.
• More tumour shrinkage. A longer gap between starting treatment and surgery allows the tumour more time to respond. For some patients this means a smaller, easier operation, and for a smaller group it means no visible tumour remains.
• A chance to identify exceptional responders. Around 1 in 4 to 1 in 3 patients respond so well to TNT that no tumour can be seen on examination, MRI or endoscopy afterwards. This is called a complete clinical response, and it opens up the option of Watch and Wait — deferring surgery while monitoring closely.

TNT is not one fixed regimen. The order of radiotherapy and chemotherapy, the radiotherapy length, and the chemotherapy drugs all vary. Two patterns are most often used:

The order matters, and so does the spacing. Your oncology team will choose the regimen that suits your tumour's size, position and biology — and the exact dates will be planned with you in advance so that you can organise time off work, support at home, and the other practical parts of getting through several months of treatment.

TNT is offered for locally advanced rectal cancer. In practical terms, this usually means one or more of:

• The cancer has grown through the muscle wall of the rectum (stage T3 or T4 on MRI).
• Lymph nodes near the rectum look involved on MRI.
• The cancer is low in the rectum and close to the muscles that control the back passage — where shrinking it first may allow a sphincter-saving operation.
• The tumour is close to the circumferential resection margin — the edge of the surgical clearance — on MRI.

Very early rectal cancers (small, confined to the bowel wall, with clear margins on imaging) usually do not need chemotherapy or radiotherapy at all — surgery alone is enough. Cancers higher up in the colon are managed differently again: radiotherapy is generally not part of the treatment plan, and chemotherapy decisions are made after surgery rather than before. TNT is specifically a rectal cancer pathway.

Side effects depend on the specific regimen, but commonly include:

• Fatigue — often the most pervasive symptom, and one that can last for some weeks after treatment finishes.
• Bowel and bladder irritation from pelvic radiotherapy — looser stools, urgency, mild bleeding, more frequent passing of urine. This usually settles within weeks.
• Nausea and reduced appetite — managed well in most cases with anti-nausea medications.
• Peripheral neuropathy (tingling or numbness in the hands and feet) from oxaliplatin, a commonly used chemotherapy drug. This usually improves but can occasionally be longer lasting.
• Mouth ulcers, hair thinning, low blood counts — possible with some chemotherapy combinations.
• Effects on fertility — pelvic radiotherapy can affect ovarian and testicular function. Fertility counselling and discussion of options (such as sperm or egg storage) before starting treatment is important for anyone of reproductive age.

Your oncology team will go through the side-effect profile of your specific regimen in detail before you start, and supports you closely during treatment.

About 8–12 weeks after the last treatment session, the response is assessed. This usually involves:

• A digital rectal examination in clinic.
• An MRI of the pelvis to see whether the tumour has shrunk, changed, or disappeared on imaging.
• A flexible sigmoidoscopy or colonoscopy with photographs to inspect the bowel lining directly.
• Sometimes a PET-CT scan if there is any concern about distant spread.

From there, one of three things usually follows:

The three possible pathways after TNT

• Standard surgical resection — if there is still tumour visible (this is the most common pathway). Surgery is typically anterior resection or, for very low cancers, abdominoperineal resection, with full removal of the tumour and surrounding lymph nodes.
• Watch and Wait — if no tumour can be detected on any of the assessments. Surgery is deferred and you are monitored closely. See Watch and Wait for rectal cancer for the details of how this pathway works.
• Further treatment — occasionally, if the tumour has not responded as hoped, the team may recommend additional therapy or proceed to surgery sooner.